EP4039249

REMOVAL OF SERINE PROTEASES BY TREATMENT WITH FINELY DIVIDED SILICON DIOXIDE

  • Status:
    EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi
  • EP appl. date:
    26.5.2011
  • EP published:
    11.2.2026
  • EP application number:
    22164436.2
  • Max expiry date:
    25.5.2031
  • Expiry date:
    10.6.2026
  • Title in English:
    REMOVAL OF SERINE PROTEASES BY TREATMENT WITH FINELY DIVIDED SILICON DIOXIDE
  • Language of the patent:
    English

Timeline

Today
26.5.2011EP application
11.2.2026EP Publication
10.6.2026Expires

Owner

  • Name:
    Takeda Pharmaceutical Company Limited
  • Address:
    1-1, Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka, JP

Inventor

  • Name:
    Teschner, Wolfgang
  • Address:
    1030 Vienna, AT
  • Name:
    Schwarz, Hans-Peter
  • Address:
    1180 Vienna, AT
  • Name:
    Madlener, Ruth
  • Address:
    1020 Vienna, AT
  • Name:
    Svatos, Sonja
  • Address:
    2413 Berg, AT
  • Name:
    Rustanbegovic, Azra
  • Address:
    1170 Vienna, AT
  • Name:
    Weber, Alfred
  • Address:
    1210 Vienna, AT

Priority

  • Number:
    2010202125
  • Date:
    26.5.2010
  • Country:
    AU
  • Number:
    78936510
  • Date:
    27.5.2010
  • Country:
    US
  • Number:
    84294410
  • Date:
    23.7.2010
  • Country:
    US

Classification

  • Categories:
    A61K 9/08, A61K 47/18, A61K 9/00, A61K 38/17, C07K 16/00, A61K 35/16, A61P 7/00, A61P 13/12, A61P 27/02, A61P 31/00, A61P 37/00, A61P 37/02, A61P 37/04, A61P 37/06, C07K 1/30, C07K 1/36, C07K 16/06

Upload documents